Anticoagulant/Antiaggregant Use and Postoperative Bleeding Risk in Patients With Bladder Tumor and Benign Prostatic Hyperplasia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-03-10

Study Completion Date

2023-01-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients who were using anticoagulant or antiaggregant medications for any reason and underwent transurethral resection of bladder tumor (TUR-BT) or transurethral resection of the prostate (TURP) or open prostatectomy (OP) due to BPH will be compared with those who were not using anticoagulant or antiplatelet medication. The rates of postoperative clot retention, presence of hematuria, reoperation due to hematuria, blood transfusion and re-admissions due to hematuria in the first postoperative month will be compared.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate

NCT02822963

Benign Prostatic Hyperplasia Prostate Cancer

WITHDRAWN

Bladder Training in Radical Prostatectomy

NCT04628351

Urinary Incontinence Quality of Life Lower Urinary Tract Symptoms

COMPLETED NA

OUTCOMES of SIMULTANEOUS TRANSURETHRAL PROSTATE and BLADDER TUMOR RESECTION VERSUS TRANSURETHRAL BLADDER TUMOR RESECTION in BLADDER TUMOR with BLADDER PROSTATE HYPERPLASIA

NCT06820502

Bladder Cancer Recurrence BPH (Benign Prostatic Hyperplasia) Bladder Cancer

ACTIVE_NOT_RECRUITING NA

Development and Pilot Evaluation of a Urethral Catheter Traction Device for Post-TURP Hemorrhage Control

NCT07287488

Simulation Study on Urethral Catheter Traction for Postoperative Hemorrhage Control After TURP

RECRUITING NA

Comparison of Different Energy Sources During TUR-P

NCT02533687

Benign Prostatic Hypertrophy

SUSPENDED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hematuria Retention, Urinary Operative Bleeding Blood Transfusion Complication

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

TURP patients using anticoagulant/antiaggregant medication

Patients who used anticoagulant/antiaggregant medication for any reason (eg: coronary artery disease, atrial fibrillation, cerebrovascular disease) before surgery and underwent endoscopic prostatectomy (TURP).